Receiving monoclonal antibodies to treat COVID-19 used to be a time-consuming process at the UPMC Hamot Infusion Center. The intravenous treatment took about 30 minutes, which came after a nearly hour ...

A one-time shot with an experimental drug halved COVID-19 patients' risk of being hospitalized with the illness compared with a placebo, a late-stage trial shows. However, the treatment may still be ...

Monoclonal antibodies, the drug cocktail used to treat patients infected with COVID-19, have proven to be an invaluable tool to limit severe disease and hospitalizations since the U.S. Food and Drug ...

Researchers from Philadelphia-based Jefferson Health have discovered that an injection of anesthetic to specific nerves in the neck may be able to improve loss of smell and taste associated with long ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. CLEVELAND, Ohio (KFOR/Storyful) – Desperate ...

Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — Most patients with wet age-related macular degeneration were able to quickly resume treatment ...

In a recent study posted to the bioRxiv* server, researchers at the United States Army Medical Research Institute of Infectious Diseases evaluated the immunogenicity of a severe acute respiratory ...

As researchers continue working on a vaccine for COVID-19, and with several clinical trials underway, a Houstonian is taking part in one of those trials. "I really needed a way to help. I mean, ...

They trust the vaccine. They want the vaccine. But millions of U.S. residents who pass out or beat feet at the sight of a hypodermic needle are risking COVID rather than getting a shot in the arm.

A COVID-19 vaccine patch produced a better immune response than an injection among mice. The patch introduces the vaccine into the skin, where there are more immune cells than muscle. The vaccine will ...